Related references
Note: Only part of the references are listed.Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis
Sailajah Janarthanan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Recent Safety Concerns With Proton Pump Inhibitors
Joan Chen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
The risks of PPI therapy
Paul Moayyedi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection
Michael D. Howell et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Health Care-Associated Clostridium difficile Infection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality
Mark Miller et al.
CLINICAL INFECTIOUS DISEASES (2010)
The Changing Epidemiology of Clostridium difficile Infections
J. Freeman et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Short- and long-term attributable costs of Clostridium difficile -: Associated disease in nonsurgical inpatients
Erik R. Dubberke et al.
CLINICAL INFECTIOUS DISEASES (2008)
Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole
Lennart Estborn et al.
DRUG SAFETY (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality
VG Loo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
